Direct isolation of donor-derived CMV-specific T-cells and their adoptive transfer for treatment or prophylaxis of CMV infection following allogeneic HSCT

被引：0
|
作者：
Lowdell, M. W. [1 ]
Thomson, K. [1 ]
Armoogum, J. [1 ]
Pang, K. [1 ]
Samuel, E. [1 ]
Desborough, M. [1 ]
Mackinnon, S. [1 ]
机构：
[1] Royal Free & UCL Med Sch, London, England
来源：
BONE MARROW TRANSPLANTATION | 2007年 / 39卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S54 / S54
页数：1
相关论文
共 50 条
  • [41] Early reconstitution of effector memory CD4+ CMV-specific T cells protects against CMV reactivation following allogeneic SCT
    B Pourgheysari
    K P Piper
    A McLarnon
    J Arrazi
    R Bruton
    F Clark
    M Cook
    P Mahendra
    C Craddock
    P A H Moss
    Bone Marrow Transplantation, 2009, 43 : 853 - 861
  • [42] Massive in vivo expansion of CMV-specific T-cells following adoptive transfer post allogeneic transplantation: Quantitation using HLA-peptide tetramers and T-cell receptor (TCR) spectratyping.
    Peggs, KS
    Verfuerth, S
    Khan, N
    Moss, PAH
    Mackinnon, S
    BLOOD, 2000, 96 (11) : 586A - +
  • [43] Treatment of a patient with severe CMV reactivation after allo-HSCT with CMV-specific T cells from a third-party donor after failure of conventional antiviral substances
    Bohme, M.
    Schetschorke, B.
    Backhaus, D.
    Kubasch, A. S.
    Pointner, R.
    Heinemann, M.
    Eiz-Vesper, B.
    Maecker-Kolhoff, B.
    Lang, P.
    Fischer, R.
    Schmidt, M.
    Maier, M.
    Liebert, U. G.
    Platzbecker, U.
    Franke, G. -N.
    ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 (SUPPL 4) : 202 - 203
  • [44] Immunization with live-attenuated Listeria encoding CMV antigen induces extensive expansion of CMV-Specific CD8+T-Cells following HSCT:: An alternative to adoptive antiviral immunotherapy.
    Roback, JD
    Lezhava, LJ
    Hesse, E
    Hillyer, CD
    Luckett, W
    Dubensky, TW
    Giedlin, M
    BLOOD, 2004, 104 (11) : 586A - 586A
  • [45] INCREASED EXPRESSION OF THE COINHIBITORS PD-1 AND BTLA ON CMV-SPECIFIC T-CELLS IS ASSOCIATED WITH SYMPTOMATIC CMV INFECTION IN RENAL TRANSPLANT PATIENTS
    Sun, Ming
    Dolff, Sebastian
    Kribben, Andreas
    Gaeckler, Anja
    Rohn, Hana
    Korth, Johannes
    Brinkhoff, Alexandra
    Lindemann, Monika
    Witzke, Oliver
    Wilde, Benjamin
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2018, 33 : 1594 - 1594
  • [46] Generation of CMV-specific T cells for adoptive immunotherapy after allogeneic BMT: A novel in vitro culture assay that is free of live virus which uses donor dendritic cells pulsed with CMV antigen.
    Verfuerth, S
    Peggs, K
    Mackinnon, S
    BLOOD, 1999, 94 (10) : 155A - 155A
  • [47] INCREASED EXPRESSION OF THE COINHIBITORS PD-1 AND BTLA ON CMV-SPECIFIC T-CELLS IS ASSOCIATED WITH SYMPTOMATIC CMV INFECTION IN RENAL TRANSPLANT PATIENTS
    Sun, Ming
    Yang, Dai
    Dolff, Sebastian
    Korth, Johannes
    Lindemann, Monika
    Brinkhoff, Alexandra
    Kribben, Andreas
    Witzke, Oliver
    Wilde, Benjamin
    TRANSPLANT INTERNATIONAL, 2019, 32 : 11 - 12
  • [48] INCREASED EXPRESSION OF THE COINHIBITORS PD-1 AND BTLA ON CMV-SPECIFIC T-CELLS IS ASSOCIATED WITH SYMPTOMATIC CMV INFECTION IN RENAL TRANSPLANT PATIENTS
    Wilde, B.
    Sun, M.
    Xu, S.
    Reinold, J.
    Dolff, S.
    Guberina, H.
    Bienholz, A.
    Lindemann, M.
    Kribben, A.
    Eisenberger, U.
    Witzke, O.
    TRANSPLANT INTERNATIONAL, 2017, 30 : 21 - 21
  • [49] CMV-Specific T Cells Restricted By Shared and Donor, but Not By Host HLA Molecules Reconstitute in the First 180 Days after Allogeneic HSCT and Protect from CMV Reactivation: Results of a Prospective Observational Study
    Noviello, Maddalena
    Tassi, Elena
    De Simone, Pantaleo
    Serio, Francesca
    Stanghellini, Maria Teresa Lupo
    Oliveira, Giacomo
    Racca, Sara
    Dvir, Roee
    Lazzari, Lorenzo
    Clerici, Daniela
    Giglio, Fabio
    Lorentino, Francesca
    Corti, Consuelo
    Bernardi, Massimo
    Brix, Liselotte
    Ciceri, Fabio
    Peccatori, Jacopo
    Greco, Raffaella
    Bonini, Chiara
    BLOOD, 2019, 134
  • [50] Third Party CMV-Specific Cytotoxic T Cells for Treatment of Antiviral Resistant CMV Infection after Hematopoietic Stem Cell Transplant
    Prockop, Susan
    Doubrovina, Ekaterina
    Hasan, Aisha N.
    Dahi, Parastoo B.
    Giralt, Sergio
    Koehne, Guenther
    Kernan, Nancy A.
    Papadopoulos, Esperanza B.
    Lehrman, Rachel
    Rodriguez-Sanchez, Irene
    O'Reilly, Richard J.
    BLOOD, 2016, 128 (22)
12345